Why India’s New Clinical Trials Push Could Matter More Than It First Seems
Most budget announcements sound bigger than they turn out to be. This one deserves more attention. In Union Budget 2026–27, the government proposed creating a network of over 1,000 accredited clinical trial sites across India under the broader Biopharma SHAKTI push. That is not a minor line item. If executed properly, it could reshape how … Read more
